Indeed, we found that transcripts for CXCL13, CXCL16, CCL19, CCL20 and CCL21 were all significantly increased in VSMCs from AAA patients while no difference was found between adventitial fibroblasts from AAAs and control aortas (Fig. 5). The gene discussed is CCL20; the disease is triple-A syndrome.